Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Research & Development of $6.8 million for Q1 2026, up 9.41% year-over-year from $6.2 million in Q1 2025, and up 0.58% quarter-over-quarter from $6.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Research & Development for 7 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 9.41% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $29.3 million (up 1.45% YoY), while the FY2025 annual figure was $29.6 million, down 12.72% from the prior year.
- Research & Development grew to $6.8 million in Q1 2026 per STVN's latest filing, from $6.8 million in the prior quarter.
- Across five years, Research & Development topped out at $11.7 million in Q1 2024 and bottomed at $6.0 million in Q4 2024.
- Historically, Research & Development has averaged $8.5 million across 5 years, with a median of $8.9 million in 2025.
- Annual changes were most pronounced in 2024 — Research & Development gained 26.56% — and 2025, when it tumbled 46.88%.
- Stevanato Group S.p.A's Research & Development stood at $10.8 million in 2022, then increased by 0.48% to $10.9 million in 2023, then slumped by 44.93% to $6.0 million in 2024, then rose by 12.82% to $6.8 million in 2025, then increased by 0.58% to $6.8 million in 2026.
- Business Quant data shows STVN's Research & Development at $6.8 million in Q1 2026, $6.8 million in Q4 2025, and $8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.83 Bn | 129.61 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 52.55 Bn | 51.69 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.76 Bn | 34.41 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.94 Bn | 32.47 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 29.10 Bn | 26.42 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.93 Bn | 24.50 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Stevanato Group S.p.A | 6.13 Bn | 6.03 Bn | 100.91 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.22 Mn |
| Mar 31, 2026 | 6.79 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 8.88 Mn |
| Jun 30, 2025 | 6.84 Mn |
| Mar 31, 2025 | 6.21 Mn |
| Dec 31, 2024 | 5.98 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 11.68 Mn |
| Dec 31, 2023 | 10.87 Mn |
| Sep 30, 2023 | 9.47 Mn |
| Jun 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 9.23 Mn |
| Dec 31, 2022 | 10.81 Mn |
| Sep 30, 2022 | 7.68 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 8.64 Mn |
| Dec 31, 2021 | 10.87 Mn |
| Sep 30, 2021 | 8.73 Mn |